NO331980B1 - Fremgangsmate for fremstilling av 5 (¿-haloacetyl)-8-substituerte oksy-(1H)-kinolin-2-oner og 5-[(R)-2-(2,5-dietylindan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolon-2-on-salter - Google Patents

Fremgangsmate for fremstilling av 5 (¿-haloacetyl)-8-substituerte oksy-(1H)-kinolin-2-oner og 5-[(R)-2-(2,5-dietylindan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolon-2-on-salter Download PDF

Info

Publication number
NO331980B1
NO331980B1 NO20055099A NO20055099A NO331980B1 NO 331980 B1 NO331980 B1 NO 331980B1 NO 20055099 A NO20055099 A NO 20055099A NO 20055099 A NO20055099 A NO 20055099A NO 331980 B1 NO331980 B1 NO 331980B1
Authority
NO
Norway
Prior art keywords
quinolin
hydroxy
acetyl
substituted oxy
solvent
Prior art date
Application number
NO20055099A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055099D0 (no
NO20055099L (no
Inventor
Gerhard Penn
Olivier Lohse
Hanspeter Schilling
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131902&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO331980(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055099D0 publication Critical patent/NO20055099D0/no
Publication of NO20055099L publication Critical patent/NO20055099L/no
Publication of NO331980B1 publication Critical patent/NO331980B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO20055099A 2003-04-02 2005-11-01 Fremgangsmate for fremstilling av 5 (¿-haloacetyl)-8-substituerte oksy-(1H)-kinolin-2-oner og 5-[(R)-2-(2,5-dietylindan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolon-2-on-salter NO331980B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45972403P 2003-04-02 2003-04-02
PCT/EP2004/003479 WO2004087668A1 (en) 2003-04-02 2004-04-01 A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones

Publications (3)

Publication Number Publication Date
NO20055099D0 NO20055099D0 (no) 2005-11-01
NO20055099L NO20055099L (no) 2006-01-02
NO331980B1 true NO331980B1 (no) 2012-05-21

Family

ID=33131902

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055099A NO331980B1 (no) 2003-04-02 2005-11-01 Fremgangsmate for fremstilling av 5 (¿-haloacetyl)-8-substituerte oksy-(1H)-kinolin-2-oner og 5-[(R)-2-(2,5-dietylindan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolon-2-on-salter

Country Status (35)

Country Link
US (1) US7605267B2 (xx)
EP (1) EP1613599B8 (xx)
JP (1) JP4726778B2 (xx)
KR (1) KR101073740B1 (xx)
CN (1) CN1774423A (xx)
AR (2) AR043825A1 (xx)
AT (1) ATE491690T1 (xx)
AU (1) AU2004226212B2 (xx)
BR (1) BRPI0409154B1 (xx)
CA (1) CA2520990C (xx)
CL (1) CL2004000706A1 (xx)
CO (1) CO5700779A2 (xx)
CY (1) CY1111515T1 (xx)
DE (1) DE602004030553D1 (xx)
DK (1) DK1613599T3 (xx)
EC (1) ECSP056059A (xx)
ES (1) ES2358193T3 (xx)
HK (1) HK1086833A1 (xx)
HR (1) HRP20110184T1 (xx)
IL (1) IL171053A (xx)
IS (1) IS2800B (xx)
MA (1) MA27761A1 (xx)
MX (1) MXPA05010616A (xx)
MY (1) MY141871A (xx)
NO (1) NO331980B1 (xx)
NZ (1) NZ542623A (xx)
PE (2) PE20050211A1 (xx)
PL (1) PL1613599T3 (xx)
PT (1) PT1613599E (xx)
RU (1) RU2339621C2 (xx)
SI (1) SI1613599T1 (xx)
TN (1) TNSN05245A1 (xx)
TW (1) TWI324151B (xx)
WO (1) WO2004087668A1 (xx)
ZA (1) ZA200507603B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
GB0413960D0 (en) * 2004-06-22 2004-07-28 Novartis Ag Organic compounds
US8198450B2 (en) 2006-06-30 2012-06-12 Novartis Ag Quinolinone derivatives and their pharmaceutical compositions
WO2013132514A2 (en) * 2012-03-09 2013-09-12 Rao Davuluri Ramamohan A novel process for the preparation of (r)-5-[2-[(5, 6-diethyl-2, 3-dihydro-1h-inden-2-yl) amino]-1-hydroxyethyl]-8-hydroxy quinolin-2(1h)-one
CN102633717B (zh) * 2012-03-30 2013-11-20 西南大学 N-乙酰-喹啉-2(1h)酮类化合物及其制备方法和应用
CN104379566B (zh) * 2012-07-11 2016-08-24 上海威智医药科技有限公司 茚达特罗中间体及茚达特罗的合成方法
CZ306252B6 (cs) 2013-03-15 2016-10-26 Zentiva, K.S. Způsob přípravy 5-[(R)-2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-(1H)-chinolin-2-onu (indacaterolu)
WO2015104718A2 (en) 2014-01-09 2015-07-16 Davuluri, Ramamohan Rao A novel process for preparation of indacaterol or its pharmaceutically acceptable salts
CN105693603B (zh) * 2014-11-24 2019-11-29 上海医药工业研究院 改良的马来酸茚达特罗制备工艺
WO2016161956A1 (zh) * 2015-04-09 2016-10-13 正大天晴药业集团股份有限公司 茚达特罗或其盐的制备方法
CN107868045A (zh) * 2016-09-28 2018-04-03 四川海思科制药有限公司 一种茚达特罗中间体的制备方法
CN108264483A (zh) * 2016-12-31 2018-07-10 天津金耀集团有限公司 一种马来酸茚达特罗的制备方法
CN109721534B (zh) * 2018-09-25 2022-05-20 四川海思科制药有限公司 一种马来酸茚达特罗中间体及其制备方法和用途
CN114751857A (zh) * 2022-04-29 2022-07-15 梯尔希(南京)药物研发有限公司 一种茚达特罗杂质的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539228B2 (xx) * 1974-01-31 1978-04-04
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
JPS5896022A (ja) * 1981-11-30 1983-06-07 Otsuka Pharmaceut Co Ltd 強心剤
ES8403457A1 (es) * 1983-01-28 1984-03-16 Espanola Farma Therapeut Procedimiento para la obtencion de un compuesto derivado de la 2-quinolinona.
ES8605239A1 (es) 1985-12-04 1986-03-16 Astur Pharma Un procedimiento para la preparacion de quinolonas sustitui-das
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
US6653323B2 (en) * 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
TWI324150B (en) * 2003-02-28 2010-05-01 Novartis Ag Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt

Also Published As

Publication number Publication date
CO5700779A2 (es) 2006-11-30
NO20055099D0 (no) 2005-11-01
KR20050119678A (ko) 2005-12-21
TWI324151B (en) 2010-05-01
EP1613599B8 (en) 2011-06-22
IL171053A (en) 2010-12-30
HK1086833A1 (en) 2006-09-29
CN1774423A (zh) 2006-05-17
WO2004087668A1 (en) 2004-10-14
AU2004226212B2 (en) 2008-02-21
PE20050211A1 (es) 2005-04-27
IS2800B (is) 2012-09-15
SI1613599T1 (sl) 2011-04-29
TNSN05245A1 (en) 2007-06-11
CL2004000706A1 (es) 2005-01-14
EP1613599B1 (en) 2010-12-15
AR043825A1 (es) 2005-08-17
AR103508A2 (es) 2017-05-17
BRPI0409154A (pt) 2006-03-28
HRP20110184T1 (hr) 2011-04-30
US7605267B2 (en) 2009-10-20
MY141871A (en) 2010-07-16
PE20100399A1 (es) 2010-06-01
DE602004030553D1 (de) 2011-01-27
ECSP056059A (es) 2006-01-27
ZA200507603B (en) 2006-11-29
DK1613599T3 (da) 2011-03-28
AU2004226212A1 (en) 2004-10-14
JP2006522055A (ja) 2006-09-28
ATE491690T1 (de) 2011-01-15
KR101073740B1 (ko) 2011-10-13
NO20055099L (no) 2006-01-02
PL1613599T3 (pl) 2011-05-31
EP1613599A1 (en) 2006-01-11
MA27761A1 (fr) 2006-02-01
BRPI0409154B1 (pt) 2014-03-25
CA2520990C (en) 2011-08-09
NZ542623A (en) 2008-07-31
IS8095A (is) 2005-10-27
RU2339621C2 (ru) 2008-11-27
TW200504025A (en) 2005-02-01
CY1111515T1 (el) 2015-08-05
JP4726778B2 (ja) 2011-07-20
PT1613599E (pt) 2011-03-17
US20060189653A1 (en) 2006-08-24
CA2520990A1 (en) 2004-10-14
MXPA05010616A (es) 2005-11-23
ES2358193T3 (es) 2011-05-06

Similar Documents

Publication Publication Date Title
NO331980B1 (no) Fremgangsmate for fremstilling av 5 (¿-haloacetyl)-8-substituerte oksy-(1H)-kinolin-2-oner og 5-[(R)-2-(2,5-dietylindan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolon-2-on-salter
KR101179302B1 (ko) 퀴놀린 유도체의 거울이성질체 선택적 제조법
EP2736894B1 (en) Method for producing benzo[b] thiophene compounds
NO331985B1 (no) Fremgangsmate for fremstilling av 5-[(R)(5,6-dietyl-indan-2-ylamino)-1-hydroksyetyl]-8-hydroksy-(1H)-kinolin-2-on-salt som er nyttig som adrenoreseptoragonist, samt mellomprodukter
AU2013359258B2 (en) Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates
DK170976B1 (da) Fremgangsmåde til sulfenylering af et N-alkylcarbamat med et sulfenylhalogenid i et opløsningsmiddel i nærvær af en syreacceptor
EP0944600B1 (en) Process for converting hydroxy heteroaromatics to arylamines
CN117886815A (zh) 白叶藤碱盐衍生物及其在防治植物病毒和杀菌方面的应用
IL26795A (en) Benzofuran derivatives and process for the manufacture thereof